Full document - International Hospital Federation

Innovation and clinical specialities: oncology
References continued
20.
Weiss JR, Moysich KB, Swede H, Weiss JR, Moysich KB, Swede H. Epidemiology of male
breast cancer. [Review] [126 refs]. Cancer Epidemiology, Biomarkers & Prevention 2005
Jan;14(1):20-6.
21.
Okobia MN, Osime U, Okobia MN, Osime U. Clinicopathological study of carcinoma of the
breast in Benin City. African Journal of Reproductive Health 2001 Aug;5(2):56-62. Abstract
Only
22.
Kidmas AT, Ugwu BT, Manasseh AN, Iya D, Opaluwa AS, Kidmas AT, et al. Male breast
malignancy in Jos University Teaching Hospital. West African Journal of Medicine 2005
Jan;24(1):36-40.
23.
Sano D, Dao B, Lankoande J, Toure B, Sakande B, Traore SS, et al. [Male breast cancer in
Africa, Apropos of 5 cases at the Ouagadougou University Teaching Hospital (Burkina Faso)].
[French]. Bulletin du Cancer 1997 Feb;84(2):175-7. Abstract Only
24.
Loefler IJ, Loefler IJ. Male breast cancer.[comment]. British Journal of Surgery 1997
Dec;84(12):1748.
25.
Bray F, McCarron P, Parkin DM, Bray F, McCarron P, Parkin DM. The changing global patterns of
female breast cancer incidence and mortality. [Review] [85 refs]. Breast Cancer Research
2004;6(6):229-39.
26.
Colditz GA, Colditz GA. Epidemiology and prevention of breast cancer. [Review] [46 refs].
Cancer Epidemiology, Biomarkers & Prevention 2005 Apr;14(4):768-72.
27.
Hortobagyi GN, de la Garza SJ, Pritchard K, Amadori D, Haidinger R, Hudis CA, et al. The global
breast cancer burden: variations in epidemiology and survival. [Review] [78 refs]. Clinical
Breast Cancer 2005 Dec;6(5):391-401. Abstract Only
28.
MacMahon B, MacMahon B. Epidemiology and the causes of breast cancer. [Review] [46 refs].
International Journal of Cancer 2006 May 15;118(10):2373-8.
29.
Basu A, Rowan BG, Basu A, Rowan BG. Genes related to estrogen action in reproduction and
breast cancer. [Review] [277 refs]. Frontiers in Bioscience 2005;10:2346-72. Abstract Only
30.
Colditz GA, Colditz GA. Estrogen, estrogen plus progestin therapy, and risk of breast cancer.
[Review] [39 refs]. Clinical Cancer Research 2005 Jan 15;11(2 Pt 2):909s-17s. Abstract Only
31.
Darbre PD, Darbre PD. Environmental oestrogens, cosmetics and breast cancer. [Review] [159
refs]. Best Practice & Research Clinical Endocrinology & Metabolism 2006 Mar;20(1):121-43.
32.
Kristensen VN, Sorlie T, Geisler J, Langerod A, Yoshimura N, Karesen R, et al. Gene expression
profiling of breast cancer in relation to estrogen receptor status and estrogen-metabolizing
enzymes: clinical implications. [Review] [24 refs]. Clinical Cancer Research 2005 Jan 15;11(2
Pt 2):878s-83s.
33.
Okobia MN, Bunker CH, Okobia MN, Bunker CH. Estrogen metabolism and breast cancer risk–a
review.[see comment]. [Review] [81 refs]. African Journal of Reproductive Health 2006
Apr;10(1):13-25.
34.
anten RJ, Mansel R, Santen RJ, Mansel R. Benign breast disorders. [Review] [89 refs]. New
England Journal of Medicine 2005 Jul 21;353(3):275-85.
35.
Gikas PD, Mansfield L, Mokbel K, Gikas PD, Mansfield L, Mokbel K. Do underarm cosmetics
cause breast cancer?. [Review] [17 refs]. International Journal of Fertility & Womens Medicine
2004 Sep;49(5):212-4.
36.
Safe S, Papineni S, Safe S, Papineni S. The role of xenoestrogenic compounds in the
development of breast cancer. [Review] [67 refs]. Trends in Pharmacological Sciences 2006
Aug;27(8):447-54. Abstract Only
37.
Friedenreich CM, Friedenreich CM. Physical activity and breast cancer risk: the effect of
menopausal status. [Review] [14 refs]. Exercise & Sport Sciences Reviews 2004
Oct;32(4):180-4.
38.
Lorincz AM, Sukumar S, Lorincz AM, Sukumar S. Molecular links between obesity and breast
cancer. [Review] [111 refs]. Endocrine-Related Cancer 2006 Jun;13(2):279-92.
39.
Kaur T, Zhang ZF, Kaur T, Zhang ZF. Obesity, breast cancer and the role of adipocytokines.
[Review] [60 refs]. Asian Pacific Journal of Cancer Prevention: Apjcp 2005 Oct;6(4):547-52.
40.
Dumitrescu RG, Shields PG, Dumitrescu RG, Shields PG. The etiology of alcohol-induced breast
cancer. [Review] [205 refs]. Alcohol 2005 Apr;35(3):213-25.
41.
Nagata C, Mizoue T, Tanaka K, Tsuji I, Wakai K, Inoue M, et al. Tobacco smoking and breast
cancer risk: an evaluation based on a systematic review of epidemiological evidence among
the Japanese population. [Review] [38 refs]. Japanese Journal of Clinical Oncology 2006
Jun;36(6):387-94.
42.
Tsubura A, Uehara N, Kiyozuka Y, Shikata N, Tsubura A, Uehara N, et al. Dietary factors
modifying breast cancer risk and relation to time of intake. [Review] [108 refs]. Journal of
Mammary Gland Biology & Neoplasia 2005 Jan;10(1):87-100.
43.
Dumitrescu RG, Cotarla I, Dumitrescu RG, Cotarla I. Understanding breast cancer risk – where
do we stand in 2005?. [Review] [107 refs]. Journal of Cellular & Molecular Medicine 2005
Jan;9(1):208-21.
44.
Buchholz TA, Wu X, Hussain A, Tucker SL, Mills GB, Haffty B, et al. Evidence of haplotype
insufficiency in human cells containing a germline mutation in BRCA1 or BRCA2. International
Journal of Cancer 2002 Feb 10;97(5):557-61.
45.
Nanda R SLCSFJSLAFeal. Genetic testing in an ethnically diverse cohort of high-risk women: a
comparative analysis of BRCA1 and BRCA2 mutations in American families of European and
African ancestry. JAMA 94(15)., 1925-33. 2005.
46.
Kean-Cowdin R SFXLPCTDSDeal. BRCA1 variants in a family study of African-American and
Latina women. Hum Genet 2005 116(6): 497-506and metastastic cancers are incurable.
2005.
47.
Fregene A NL. Breast cancer in sub-Saharan Africa : how does it relate to breast cancer in
African-American women? Cancer 103(8), 1540-50 Breast cancer in sub-Saharan Africa : how
does it relate to breast cancer in African-American women? 2005.
48.
Lacroix M, Leclercq G, Lacroix M, Leclercq G. The “portrait” of hereditary breast cancer.
[Review] [79 refs]. Breast Cancer Research & Treatment 2005 Feb;89(3):297-304.
49.
Rubinstein WS, Rubinstein WS. Hereditary breast cancer in Jews. [Review] [110 refs]. Familial
Cancer 2004;3(3-4):249-57.
50.
Smith KL, Robson ME, Smith KL, Robson ME. Update on hereditary breast cancer. [Review] [50
refs]. Current Oncology Reports 2006 Jan;8(1):14-21.
51.
Thull DL, Vogel VG, Thull DL, Vogel VG. Recognition and management of hereditary breast
cancer syndromes. [Review] [80 refs]. Oncologist 2004;9(1):13-24.
52.
Antoniou AC, Easton DF, Antoniou AC, Easton DF. Risk prediction models for familial breast
cancer. [Review] [89 refs]. Future Oncology 2006 Apr;2(2):257-74.
53.
Baltzell K, Wrensch MR, Baltzell K, Wrensch MR. Strengths and limitations of breast cancer risk
assessment. [Review] [60 refs]. 2005 May;Online. 32(3):605-16.
54.
Vogel V, Vogel V. Chemoprevention in breast cancer. [Review] [5 refs]. Clinical Advances in
Hematology & Oncology 2005 Jul;3(7):531-3.
55.
Singletary SE, Connolly JL, Singletary SE, Connolly JL. Breast cancer staging: working with the
sixth edition of the AJCC Cancer Staging Manual. [Review] [28 refs]. CA: a Cancer Journal for
Clinicians 2006 Jan;56(1):37-47.
56.
Yamamoto D, Tanaka K, Yamamoto D, Tanaka K. A review of mammary ductoscopy in breast
cancer.[see comment]. [Review] [31 refs]. Breast Journal 2004 Jul;10(4):295-7.
57.
Leris C, Mokbel K, Leris C, Mokbel K. The role of mammary ductoscopy in the assessment of
breast disease. [Review] [15 refs]. International Journal of Fertility & Womens Medicine 2004
Sep;49(5):200-2.
58.
Sarakbi WA, Escobar PF, Mokbel K, Sarakbi WA, Escobar PF, Mokbel K. The potential role of
breast ductoscopy in breast cancer screening. [Review] [22 refs]. International Journal of
Fertility & Womens Medicine 2005 Sep;50(5 Pt 1):208-11.
59.
Sauter E, Sauter E. Breast cancer detection using mammary ductoscopy. [Review] [27 refs].
Future Oncology 2005 Jun;1(3):385-93.
60.
Fine RE, Staren ED, Fine RE, Staren ED. Updates in breast ultrasound. [Review] [105 refs].
Surgical Clinics of North America 2004 Aug 20;84(4):1001-34.
61.
Rubio IT, Henry-Tillman R, Klimberg VS, Rubio IT, Henry-Tillman R, Klimberg VS. Surgical use of
breast ultrasound. [Review] [72 refs]. Surgical Clinics of North America 2003 Aug;83(4):771-
88.
62.
Hylton N, Hylton N. Magnetic resonance imaging of the breast: opportunities to improve breast
cancer management.[see comment]. [Review] [54 refs]. Journal of Clinical Oncology 2005 Mar
10;23(8):1678-84.
63.
Lalonde L, David J, Trop I, Lalonde L, David J, Trop I. Magnetic resonance imaging of the
breast: current indications. [Review] [24 refs]. Canadian Association of Radiologists Journal
2005 Dec;56(5):301-8.
64.
Pavic D, Koomen MA, Kuzmiak CM, Lee YH, Pisano ED, Pavic D, et al. The role of magnetic
resonance imaging in diagnosis and management of breast cancer. [Review] [121 refs].
Technology in Cancer Research & Treatment 2004 Dec;3(6):527-41.
65.
Barton MB, Barton MB. Breast cancer screening. Benefits, risks, and current controversies.
[Review] [18 refs]. Postgraduate Medicine 1933 Jun 20;118(2):27-8.
66.
Duffy SW, Smith RA, Gabe R, Tabar L, Yen AM, Chen TH, et al. Screening for breast cancer.
[Review] [100 refs]. Surgical Oncology Clinics of North America 2005 Oct;14(4):671-97.
67.
Retsky M, Demicheli R, Hrushesky W, Retsky M, Demicheli R, Hrushesky W. Breast cancer
screening: controversies and future directions. [Review] [96 refs]. Current Opinion in Obstetrics
& Gynecology 2003 Feb;15(1):1-8.
68.
Gaskie S, Nashelsky J, Gaskie S, Nashelsky J. Clinical inquiries. Are breast self-exams or
clinical exams effective for screening breast cancer?. [Review] [10 refs]. Journal of Family
Practice 2005 Sep;54(9):803-4.
69.
Smith RA, Caleffi M, Albert US, Chen THH, Duffy SW, Franceschi D, et al. Breast Cancer in
Limited-Resource Countries: Early Detection and Access to Care. The Breast Journal
2006;12(s1):S16-S26.
70.
Bradley SJ WDBDL. Alternatives in the surgical management of in situ breast cancer. A metaanalysis
of outcome. American Surgeon 56, 428-432. 1990.
71.
Robert W.Carlson et al. NCCN ® Practice Guidelines in Oncology. 1, 1-100. 2007.
72.
Olivotto I, Levine M, Steering Committee on Clinical Practice Guidelines for the Care and
Treatment of Breast Cancer., Olivotto I, Levine M, Steering Committee on Clinical Practice
Guidelines for the Care and Treatment of Breast Cancer. Clinical practice guidelines for the
care and treatment of breast cancer: the management of ductal carcinoma in situ (summary
of the 2001 update). [Review] [8 refs]. CMAJ Canadian Medical Association Journal 2001 Oct
2;165(7):912-3.
73.
Schwartz GF, Solin LJ, Olivotto IA, Ernster VL, Pressman PI, Schwartz GF, et al. Consensus
Conference on the Treatment of In Situ Ductal Carcinoma of the Breast, April 22-25, 1999.
[Review] [3 refs]. Cancer 2000 Feb 15;88(4):946-54.
74.
Hanley KY, Beckman A, Hayne M, Hanley KY, Beckman A, Hayne M. Advances in treating early
breast cancer. [Review] [34 refs]. JAAPA 2005 Nov;18(11):54-62.
75.
Luini A, Gatti G, Galimberti V, Zurrida S, Intra M, Gentilini O, et al. Conservative treatment of
breast cancer: its evolution. [Review] [17 refs]. Breast Cancer Research & Treatment 2005
Dec;94(3):195-8.
76.
Guarneri V, Conte PF, Guarneri V, Conte PF. The curability of breast cancer and the treatment of
advanced disease. [Review] [106 refs]. European Journal of Nuclear Medicine & Molecular
Imaging 2004 Jun;31 Suppl 1:S149-S161.
77.
Meric-Bernstam F, Meric-Bernstam F. Breast conservation in breast cancer: surgical and
adjuvant considerations. [Review] [53 refs]. Current Opinion in Obstetrics & Gynecology 2004
Feb;16(1):31-6.
78.
Fisher B ASBJeal. Twenty-year follow-up of a randomized trial comparing total mastectomy,
Hospital and Healthcare Innovation Book 2009/2010 107